Tela Bio Slides Yet Sees Strong Soft‑Tissue Reconstruction Momentum in Volatile Market
Tela Bio slides amid biotech softness yet stays focused on Phase II soft‑tissue scaffold trials that could unlock new revenue and upside.
3 minutes to read
TELA BIO INC
Tela Bio (TELA) Stock Falls 0.92% to $1.09 Amid Strong Biotech Competition
Tel Bio (TELA) drops 0.92% to $1.09, with a $49.2 M market cap and 23.4% monthly decline—track its biotech rivals and soft‑tissue innovation insights.
One minute to read
Tela Bio (TELA) Surges 12.4% as Investors Reassess Soft‑Tissue Pipeline Potential
12.37 % surge in Tela Bio (TELA) stock shows investor optimism on its soft‑tissue reconstruction pipeline, highlighting a potential breakout above its 200‑day SMA.
3 minutes to read
Tela Bio (TELA) Shares Drop 25% MTD: $1.09, Market Cap $44M, 200‑Day SMA $0.86
Tela Bio’s latest performance shows a 25% slide, trading around $1.09 with a $44M market cap. Discover key metrics, trends & how it ranks with peers.
2 minutes to read